アステラス薬：Astellas Announces Acceptance by the EMA of a Variation Application for Regulatory Review forUse of XTANDI in Sensitive Prostate Cancer - 有報キャッチャー

アステラス薬（4503）　Astellas Announces Acceptance by the EMA of a Variation Application for Regulatory Review forUse of XTANDI in Sensitive Prostate Cancer 2019/07/24

/-

読み込み中…